Valderm
Valderm develops second generation anthracycline valrubicin for the innovative topical treatment of hyperproliferative skin diseases.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Valderm Information
Geographic Data
Address:
City: Lyngby
State: Hovedstaden
Zip:
Country: Denmark
Financial Info
Stage:
series a
Raised Last:
$3M
Raised Total:$3M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Valderm ApS is focused on the development of the second generation anthracycline valrubicin for innovative once daily topical treatment of hyperproliferative skin diseases e.g. psoriasis. Preclinical studies have confirmed the anti-proliferative effect of valrubicin and an attractive safety profile upon repeated topical applications has been documented.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2007 | Series A | 1 | $3.4M |
Seed Capital Seed Capital |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
